Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3320 | 1809 | 30.5 | 73% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
551 | 3 | FABRY DISEASE//GAUCHER DISEASE//LYSOSOMAL STORAGE DISEASE | 18099 |
3320 | 2 | FABRY DISEASE//ALPHA GALACTOSIDASE A//ANDERSON FABRY DISEASE | 1809 |
4302 | 1 | FABRY DISEASE//ALPHA GALACTOSIDASE A//ANDERSON FABRY DISEASE | 1809 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | FABRY DISEASE | authKW | 12459537 | 47% | 87% | 851 |
2 | ALPHA GALACTOSIDASE A | authKW | 2692090 | 10% | 91% | 175 |
3 | ANDERSON FABRY DISEASE | authKW | 1018695 | 4% | 93% | 65 |
4 | ENZYME REPLACEMENT THERAPY | authKW | 939646 | 12% | 25% | 225 |
5 | GLOBOTRIAOSYLCERAMIDE | authKW | 749837 | 4% | 58% | 76 |
6 | AGALSIDASE ALFA | authKW | 708874 | 2% | 100% | 42 |
7 | AGALSIDASE BETA | authKW | 472583 | 2% | 100% | 28 |
8 | DEV METAB NEUROL BRANCH | address | 418108 | 4% | 33% | 74 |
9 | FABRY | authKW | 323774 | 1% | 71% | 27 |
10 | ALPHA GALACTOSIDASE A DEFICIENCY | authKW | 304645 | 1% | 95% | 19 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Genetics & Heredity | 4701 | 22% | 0% | 398 |
2 | Urology & Nephrology | 2994 | 12% | 0% | 225 |
3 | Medicine, Research & Experimental | 2615 | 15% | 0% | 272 |
4 | Cardiac & Cardiovascular System | 826 | 10% | 0% | 173 |
5 | Endocrinology & Metabolism | 735 | 9% | 0% | 161 |
6 | Medicine, General & Internal | 723 | 11% | 0% | 194 |
7 | Clinical Neurology | 714 | 10% | 0% | 182 |
8 | Medical Laboratory Technology | 346 | 3% | 0% | 46 |
9 | Transplantation | 246 | 3% | 0% | 51 |
10 | Dermatology | 226 | 3% | 0% | 58 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DEV METAB NEUROL BRANCH | 418108 | 4% | 33% | 74 |
2 | LYSOSOMAL STORAGE DISORDERS UNIT | 186059 | 1% | 53% | 21 |
3 | CARDIAC REPAIR REGENERAT | 124280 | 0% | 82% | 9 |
4 | REFERENCE MALAD FABRY MALAD HEREDITAI TI | 113922 | 0% | 75% | 9 |
5 | LYSOSOMAL STORAGE DISORDERS | 105157 | 0% | 69% | 9 |
6 | LYSOSOMAL STORAGE DIS | 90002 | 1% | 44% | 12 |
7 | FABRY INTERDISCIPLINARY THER Y FAZIT | 67512 | 0% | 100% | 4 |
8 | CLIN NEPHROSCI | 67504 | 0% | 50% | 8 |
9 | ALBRECHT KOSSEL NEUROREGENERAT | 58555 | 1% | 18% | 19 |
10 | CHARLES DENT METAB UNIT | 52552 | 1% | 17% | 18 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF INHERITED METABOLIC DISEASE | 27498 | 5% | 2% | 86 |
2 | MOLECULAR GENETICS AND METABOLISM | 20720 | 3% | 2% | 62 |
3 | ORPHANET JOURNAL OF RARE DISEASES | 6043 | 1% | 2% | 20 |
4 | GENETICS IN MEDICINE | 4154 | 1% | 1% | 20 |
5 | ACTA PAEDIATRICA | 3976 | 2% | 1% | 44 |
6 | REVISTA DE NEFROLOGIA DIALISIS Y TRASPLANTE | 3238 | 0% | 3% | 6 |
7 | CLINICAL GENETICS | 3138 | 2% | 1% | 31 |
8 | REVUE DE MEDECINE INTERNE | 2232 | 1% | 1% | 23 |
9 | JOURNAL OF HUMAN GENETICS | 1845 | 1% | 1% | 16 |
10 | CONTRIBUTIONS TO NEPHROLOGY | 1839 | 1% | 1% | 13 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FABRY DISEASE | 12459537 | 47% | 87% | 851 | Search FABRY+DISEASE | Search FABRY+DISEASE |
2 | ALPHA GALACTOSIDASE A | 2692090 | 10% | 91% | 175 | Search ALPHA+GALACTOSIDASE+A | Search ALPHA+GALACTOSIDASE+A |
3 | ANDERSON FABRY DISEASE | 1018695 | 4% | 93% | 65 | Search ANDERSON+FABRY+DISEASE | Search ANDERSON+FABRY+DISEASE |
4 | ENZYME REPLACEMENT THERAPY | 939646 | 12% | 25% | 225 | Search ENZYME+REPLACEMENT+THERAPY | Search ENZYME+REPLACEMENT+THERAPY |
5 | GLOBOTRIAOSYLCERAMIDE | 749837 | 4% | 58% | 76 | Search GLOBOTRIAOSYLCERAMIDE | Search GLOBOTRIAOSYLCERAMIDE |
6 | AGALSIDASE ALFA | 708874 | 2% | 100% | 42 | Search AGALSIDASE+ALFA | Search AGALSIDASE+ALFA |
7 | AGALSIDASE BETA | 472583 | 2% | 100% | 28 | Search AGALSIDASE+BETA | Search AGALSIDASE+BETA |
8 | FABRY | 323774 | 1% | 71% | 27 | Search FABRY | Search FABRY |
9 | ALPHA GALACTOSIDASE A DEFICIENCY | 304645 | 1% | 95% | 19 | Search ALPHA+GALACTOSIDASE+A+DEFICIENCY | Search ALPHA+GALACTOSIDASE+A+DEFICIENCY |
10 | GLOBOTRIAOSYLSPHINGOSINE | 219413 | 1% | 100% | 13 | Search GLOBOTRIAOSYLSPHINGOSINE | Search GLOBOTRIAOSYLSPHINGOSINE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GERMAIN, DP , (2010) FABRY DISEASE.ORPHANET JOURNAL OF RARE DISEASES. VOL. 5. ISSUE . P. - | 313 | 92% | 135 |
2 | EL-ABASSI, R , SINGHAL, D , ENGLAND, JD , (2014) FABRY'S DISEASE.JOURNAL OF THE NEUROLOGICAL SCIENCES. VOL. 344. ISSUE 1-2. P. 5 -19 | 198 | 93% | 15 |
3 | MEHTA, A , BECK, M , EYSKENS, F , FELICIANI, C , KANTOLA, I , RAMASWAMI, U , ROLFS, A , RIVERA, A , WALDEK, S , GERMAIN, D , (2010) FABRY DISEASE: A REVIEW OF CURRENT MANAGEMENT STRATEGIES.QJM-AN INTERNATIONAL JOURNAL OF MEDICINE. VOL. 103. ISSUE 9. P. 641 -659 | 135 | 94% | 59 |
4 | SCHIFFMANN, R , (2009) FABRY DISEASE.PHARMACOLOGY & THERAPEUTICS. VOL. 122. ISSUE 1. P. 65-77 | 139 | 84% | 92 |
5 | SHARMA, A , SARTORI, M , ZARAGOZA, JJ , VILLA, G , LU, RH , FAGGIANA, E , BROCCA, A , DI LULLO, L , FERIOZZI, S , RONCO, C , (2015) FABRY'S DISEASE: AN EXAMPLE OF CARDIORENAL SYNDROME TYPE 5.HEART FAILURE REVIEWS. VOL. 20. ISSUE 6. P. 689 -708 | 144 | 85% | 0 |
6 | ZARATE, YA , HOPKIN, RJ , (2008) LYSOSOMAL STORAGE DISEASE 3 - FABRY'S DISEASE.LANCET. VOL. 372. ISSUE 9647. P. 1427-1435 | 89 | 98% | 220 |
7 | SIVLEY, MD , (2013) FABRY DISEASE: A REVIEW OF OPHTHALMIC AND SYSTEMIC MANIFESTATIONS.OPTOMETRY AND VISION SCIENCE. VOL. 90. ISSUE 2. P. E63-E78 | 114 | 97% | 1 |
8 | SCHIFFMANN, R , RIES, M , (2016) FABRY DISEASE: A DISORDER OF CHILDHOOD ONSET.PEDIATRIC NEUROLOGY. VOL. 64. ISSUE . P. 10 -20 | 108 | 89% | 0 |
9 | PISANI, A , VISCIANO, B , ROUX, GD , SABBATINI, M , PORTO, C , PARENTI, G , IMBRIACO, M , (2012) ENZYME REPLACEMENT THERAPY IN PATIENTS WITH FABRY DISEASE: STATE OF THE ART AND REVIEW OF THE LITERATURE.MOLECULAR GENETICS AND METABOLISM. VOL. 107. ISSUE 3. P. 267 -275 | 102 | 92% | 27 |
10 | LIDOVE, O , MEHTA, A , PASTORES, GM , KAMPMANN, C , CARVALHO, LR , PARINI, R , FIGUERA, LE , NICHOLLS, K , REISIN, R , PINTOS-MORELL, G , ET AL (2010) EFFECTS OF ENZYME REPLACEMENT THERAPY IN FABRY DISEASE-A COMPREHENSIVE REVIEW OF THE MEDICAL LITERATURE.GENETICS IN MEDICINE. VOL. 12. ISSUE 11. P. 668 -679 | 98 | 100% | 34 |
Classes with closest relation at Level 2 |